FURTHER CHANGES ARE COMING to the in vitro diagnostics (IVD) marketplace. On October 19, Abbott Laboratories, Inc., announced that it would separate into two publicly-traded companies sometime in 2012. One business will be the medical devices and diagnostics business. It will have about $22 billion in annual sales. Of this total, about $4 billion comes from […]
- "IVD Update"
Abbott Says It Will Split into Two Firms in 2012
One company will be medical devices and diagnostics, the other company will be pharmaceutical products
- By Robert Michel
- > From the Volume XVIII No. 15 - November 7, 2011 Issue
